Zu "1143503-69-8" wurden 2 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
Anti-IL-17A Antibody (Ixekizumab)
Artikelnummer: BPS-84295-1
Ixekizumab, also known as LY2439821,is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A. It directly blocks IL-17A binding to IL-17RA (IL-17receptor) but does not bind other IL-17 family members. Ixekizumab is used for the research of moderate-to-severe plaque psoriasis....
| Schlagworte: | IL17A, Interleukin-17A, Cytotoxic T-lymphocyte-associated antigen 8 |
| Anwendung: | ELISA, FC, FA |
| Wirt: | Human |
| Spezies-Reaktivität: | human |
| CAS | 1143503-69-8 |
ab 453,00 €
Ixekizumab
Artikelnummer: TGM-T38105-10mg
Description: Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM. It blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members. Ixekizumab is used for the treatment of moderate to severe plaque...
| Schlagworte: | LY2439821 |
| Anwendung: | Targets interleukin 17A (IL17A, CTLA8) |
| CAS | 1143503-69-8 |
ab 100,00 €
